Rhodiola Rosea Therapy of Major Depressive Disorder
Status:
Completed
Trial end date:
2013-07-01
Target enrollment:
Participant gender:
Summary
Prior research has shown that Rhodiola rosea may be an effective, short-term, anti-depressant
therapy. This study will examine the anti-depressant effect of Rhodiola rosea vs. a
conventional, anti-depressant drug in the treatment of major depression.
Phase:
Phase 3
Details
Lead Sponsor:
University of Pennsylvania
Collaborator:
National Center for Complementary and Integrative Health (NCCIH)